Company news
Exagen Inc. news in 2019
Exagen Inc.'s news releases, calls and decks from 2019, newest first.
Exagen Announces Addition to Russell 3000® and 2000® Indexes
December 15, 2019
Exagen extends agreement with GSK for a third year to drive greater awareness about challenges facing lupus diagnosis and management
November 21, 2019
Exagen Inc. Announces $26.2 Million Debt Refinancing
November 20, 2019
Exagen Inc. Reports Third Quarter 2019 Results
November 11, 2019
Exagen to Announce Third Quarter 2019 Financial Results on November 12th, 2019
October 28, 2019
Exagen Announces Publication of Two Key Studies Validating Clinical Performance of AVISE® Lupus in Patients with Probable SLE and Demonstrating Superior Clinical Utility Compared to Standard Diagnostic Testing
October 14, 2019
Exagen Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
September 22, 2019